Checkpoint Therapeutics Insider Sold Shares Worth $3,074,764, According to a Recent SEC Filing
Lake Street Maintains Checkpoint Therapeutics(CKPT.US) With Buy Rating, Raises Target Price to $7
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
Analysts Offer Insights on Healthcare Companies: Checkpoint Therapeutics (CKPT) and Roche Holding AG (OtherRHHVF)
Trending Stocks Today | Sidus Space Shoots up 59.44% Pre-Market
Checkpoint Therapeutics' Shares Rise After Securing First FDA Approval
